Core Points - Cara Therapeutics, Inc. has announced a 1-for-3 reverse stock split of its outstanding shares of common stock [1] - The company's common stock will begin trading under the new name "Tvardi Therapeutics, Inc." and the new symbol "TVRD" following the merger with Tvard Therapeutics, Inc. [2] - The reverse stock split was approved by stockholders and will reduce the number of outstanding shares from approximately 4.6 million to approximately 1.5 million [3][4] Company Overview - Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing oral small molecule therapies targeting STAT3 for fibrosis-driven diseases [7] - Cara Therapeutics is a biopharmaceutical company that has developed an IV formulation of difelikefalin for treating moderate-to-severe pruritus associated with advanced kidney disease [8]

Core Viewpoint - Antelope Enterprise Holdings Limited will implement a 1-for-40 reverse stock split of its Class A ordinary shares effective April 4, 2025, to comply with NASDAQ's minimum bid price requirement of $1.00 per share [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split will consolidate every 40 issued and outstanding Ordinary Shares into one Ordinary Share, reducing the total number of shares from approximately 41,430,051 to about 1,035,752 [3]. - Shareholders entitled to fractional shares will receive one full share instead of a fractional share [3]. - All outstanding stock options, warrants, and other rights to purchase the Company's Ordinary Shares will be adjusted proportionately due to the reverse stock split [3]. Group 2: Compliance and Listing Requirements - The reverse stock split is aimed at regaining compliance with NASDAQ's requirement that the Company's common stock must have a closing bid price of $1.00 or more for at least ten consecutive trading days by April 30, 2025 [2]. - There is uncertainty regarding whether the Ordinary Shares will remain above the $1.00 minimum bid price after the reverse split, which is crucial for maintaining NASDAQ listing compliance [2]. Group 3: Company Overview - Antelope Enterprise holds a 51% ownership stake in Hainan Kylin Cloud Services Technology Co. Ltd, which operates a livestreaming e-commerce business in China, providing access to over 800,000 hosts and influencers [5].

Core Viewpoint - MarketWise, Inc. will implement a 1-for-20 reverse stock split to enhance its stock price and meet Nasdaq listing requirements, effective April 2, 2025 [1][6]. Group 1: Reverse Stock Split Details - The reverse stock split will reduce the number of issued and outstanding Class A common stock from approximately 49,487,262 shares to about 2,474,363 shares, and Class B common stock from approximately 276,623,803 shares to about 13,831,190 shares [3]. - The authorized Class A common stock will decrease from 950,000,000 shares to 47,500,000 shares, and Class B common stock from 300,000,000 shares to 15,000,000 shares [5]. - Fractional shares resulting from the reverse stock split will be paid in cash based on the closing price on April 2, 2025 [6]. Group 2: Rationale and Expectations - The reverse stock split aims to bring the stock price into a range more aligned with the company's market capitalization, making it more appealing to institutional investors and improving market perception [3]. - The company believes that the higher share price will help meet Nasdaq's minimum bid price requirement of $1.00 per share [6]. Group 3: Company Overview - MarketWise is a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self-directed investors [7]. - The company has over 25 years of operating history and serves millions of subscribers, offering its products through various digital platforms [8].